Early stage esophageal cancer patients can reach 95% survival rate in 5 years after timely treatment, so it is recommended that patients take treatment measures as early as possible. Early stage esophageal cancer patients with timely radical treatment have good prognosis, and the 5-year survival rate of most patients can reach 95% after treatment. For patients with early esophageal cancer, endoscopic mucosal resection, endoscopic submucosal dissection, and open thoracic surgery and thoracolaparoscopic surgery can be adopted for some patients. Patients with early esophageal cancer can also be treated by radiation irradiation, and some of them can also apply chemotherapeutic drugs such as cisplatin and paclitaxel under the guidance of doctors. Early stage esophageal cancer patients need to seek for medical treatment in time, and they can choose appropriate measures for treatment under the guidance of doctors, and the 5-year survival rate of most of the patients after timely treatment is generally above 95%.